LANTERN PHARMA INC (LTRN)
US51654W1018 - Common Stock
| Shares Outstanding | 10.74M |
| Float | 9.12M |
| Owners (insider) | 14.23% |
| Owners (institutional) | 10.58% |
| Owners (insider) change | 0% |
| Owners (institutional) change | -0.65% |
Insider Transactions
Top Institutional Holders
Insider Owners
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Feb 27, 2024 | BIOS Fund I, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | BIOS Fund I QP, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | BIOS Fund II, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | BIOS Fund II QP, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | BIOS Fund II NT, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | Bios Equity Partners, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | Bios Equity Partners II, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | BIOS Capital Management, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | BIOS Advisors GP, LLC | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | Kreis Leslie W. | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | Cavu Management, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | Cavu Advisors, LLC | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | BP Directors, LP | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Feb 27, 2024 | Fletcher Aaron G.L. | Open Market Sale | 144000 | 4.70 | $ 676,294.06 |
| Jan 17, 2024 | Fletcher Aaron G.L. | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BIOS Fund I, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BIOS Fund I QP, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BIOS Fund II, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BIOS Fund II QP, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BIOS Fund II NT, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | Bios Equity Partners, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | Bios Equity Partners II, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BIOS Capital Management, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BIOS Advisors GP, LLC | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | Fletcher Aaron G.L. | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BIOS Fund I, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BIOS Fund I QP, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BIOS Fund II, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BIOS Fund II QP, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BIOS Fund II NT, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | Bios Equity Partners, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | Bios Equity Partners II, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BIOS Capital Management, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BIOS Advisors GP, LLC | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | Kreis Leslie W. | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | Cavu Management, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | Cavu Advisors, LLC | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | BP Directors, LP | Other Aquisition | 79021 | 3.13 | $ 247,335.73 |
| Jan 17, 2024 | Kreis Leslie W. | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | Cavu Management, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | Cavu Advisors, LLC | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Jan 17, 2024 | BP Directors, LP | Open Market Sale | 58889 | 4.20 | $ 247,333.80 |
| Nov 29, 2023 | Cavu Management, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | Cavu Advisors, LLC | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BP Directors, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | Fletcher Aaron G.L. | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BIOS Fund I, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BIOS Fund I QP, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BIOS Fund II, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BIOS Fund II QP, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BIOS Fund II NT, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | Bios Equity Partners, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | Bios Equity Partners II, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BIOS Capital Management, LP | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | BIOS Advisors GP, LLC | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |
| Nov 29, 2023 | Kreis Leslie W. | Open Market Sale | 145348 | 3.44 | $ 499,997.12 |